Ist phalaenopsis sogo yukidian flower extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS/CIR safety assessment identifying reproductive hazards, and no peer‑reviewed reproductive/toxicology data found for Phalaenopsis sogo yukidian flower extract in the common regulatory sources (CosIng, PubMed, PubChem, ECHA). Therefore default hazard and mechanism ratings are 0 and exposure from topical cosmetic use is judged negligible (no data indicating systemic availability). Sources checked: ECHA Annex VI (no harmonised classification), CosIng (botanical extract listing), PubMed (no reproductive/toxicity studies), PubChem (no GHS reproductive classification).
Related ingredients
Frequently asked questions
- Ist phalaenopsis sogo yukidian flower extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS/CIR safety assessment identifying reproductive hazards, and no peer‑reviewed reproductive/toxicology data found for Phalaenopsis sogo yukidian flower extract in the common regulatory sources (CosIng, PubMed, PubChem, ECHA). Therefore default hazard and mechanism ratings are 0 and exposure from topical cosmetic use is judged negligible (no data indicating systemic availability). Sources checked: ECHA Annex VI (no harmonised classification), CosIng (botanical extract listing), PubMed (no reproductive/toxicity studies), PubChem (no GHS reproductive classification).
- Ist phalaenopsis sogo yukidian flower extract während des Stillens sicher?
- Same rationale as pregnancy: no authoritative reproductive/breastmilk transfer data or harmonised flags in regulatory databases; topical cosmetic use is unlikely to give substantial systemic levels that would contraindicate breastfeeding. Sources checked: CIR/SCCS (no specific opinion), ECHA Annex VI, PubMed, CosIng.
- Ist phalaenopsis sogo yukidian flower extract sicher für Babyhaut?
- No infant‑specific toxicology data located. Hazard and mechanism remain 0 by default. Exposure was increased by +1 for baby skin (e=1) because botanicals are not completely non‑absorbable and infants have higher dermal absorption/SA:weight; however there is no evidence of specific reproductive or developmental hazard for this ingredient. Sources checked: PubMed (no infant studies), CosIng, ECHA Annex VI.
- Wie bewertet VeriMom phalaenopsis sogo yukidian flower extract?
- VeriMom bewertet phalaenopsis sogo yukidian flower extract mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu phalaenopsis sogo yukidian flower extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu phalaenopsis sogo yukidian flower extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.